The Australia Surgical Gowns and Drapes Market was valued at $30.5 Million in 2025 and projected to reach to $37 Million by 2030, representing a compound annual growth rate of 3.9%. Australia's surgical gowns and drapes market demonstrates steady growth momentum, supported by the country's robust healthcare infrastructure and commitment to infection control excellence.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia's surgical gowns and drapes market is valued at USD 30.5 million in 2025, with projected growth to USD 37.0 million by 2030, reflecting a steady CAGR of 3.9%.
Stringent infection control standards and TGA regulations in Australia drive consistent demand for high-quality, certified surgical protective wear across healthcare facilities.
Australia's advanced healthcare system, including public hospitals and private surgical centers, supports sustained demand for premium surgical gowns and drapes.
Increasing surgical procedures, aging population demographics, and heightened focus on infection prevention protocols are key factors propelling market expansion in Australia.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | REINFORCED GOWNS (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.1% from 2025 to 2030 |
| Largest Segment | STERILE PRODUCTS (Sterility) |
| Market Size Base Year (Billions) | ~USD 4.69 (2025) |
| Revenue Forecast (Billions) | ~USD 6.01 (2030) |
| Segments Covered | Product Type, Usage Pattern, Type, Application 2023–2030, Material, Sterility, Application |
7 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGICAL CENTERS | 10.6 | 11.3 | 11.9 | 12.5 | 13.3 | 14.1 | 15 | 16 | 6.1 |
| HOSPITALS | 32.1 | 33.5 | 34.7 | 36 | 37.4 | 39 | 40.8 | 42.7 | 4.3 |
| OTHER END USERS | 2.3 | 2.4 | 2.4 | 2.5 | 2.6 | 2.6 | 2.7 | 2.8 | 3.3 |
| TOTAL | 44.9 | 47.2 | 49 | 51 | 53.2 | 55.7 | 58.5 | 61.5 | 4.7 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| CARDINAL HEALTH | United States | Public Company | Branded and generic pharmaceutical distribution,Specialty pharmaceutical and manufacturer services,Medical, surgical, and laboratory products (Cardinal-branded and national brands), |
| OWENS & MINOR | United States | Public Company | In-home diabetes care and delivery,Home respiratory therapy (oxygen and NIV),Obstructive sleep apnea (CPAP/BiPAP and support), |
| MCKESSON CORPORATION | United States | Public Company | North American Pharmaceutical distribution,Oncology & Multispecialty,Prescription Technology Solutions, |
| MöLNLYCKE AB | Sweden | Private Company | Advanced and chronic wound care,Operating room solutions and custom procedure trays,Surgical gloves, |
| SOLVENTUM | United States | Public Company | Medsurg,Dental Solutions,Health Information Systems, |
| PAUL HARTMANN AG | Germany | Public Company | Wound Care,Incontinence Management,Infection Management, |
| WINNER MEDICAL, CO., LTD. | China | Public Company | Medical Consumables – Wound Care,Medical Consumables – Operating Room & PPE,Consumer Products – Home Wound Care & First Aid, |
| STERIS | Ireland | Public Company | Healthcare sterilization and decontamination equipment,Operating room equipment and procedural infrastructure,Consumables and chemistries, |
| ALPHAPROTECH | Canada | Public Company | Building Supply – Housewraps and Accessories,Building Supply – Synthetic Roof Underlayments,Disposable Protective Apparel – Garments, |
| HENRY SCHEIN | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, peripheral interventions, LAAC/Watchman),Endoscopy (GI, pancreaticobiliary, single-use scopes, infection prevention),Urology and Pelvic Health, |
Cardinal Health is a United States-based public company founded in 1979 that employs 55,392 people. The company operates as a major healthcare services and products distributor.
Owens & Minor is a United States-based public company founded in 1882 with 6,500 employees. The company operates as a healthcare services and products distributor.
McKesson Corporation is a United States-based public company founded in 1833 with 42,300 employees. The company is a leading healthcare services and pharmaceutical distributor.
Mölnlycke AB is a Sweden-based private company founded in 1849 with 8,463 employees. The company manufactures and distributes medical devices and healthcare products.
Solventum is a United States-based public company founded in 2023 with 20,584 employees. The company operates in the healthcare and industrial sectors.
Paul Hartmann AG is a Germany-based public company founded in 1818 with 10,066 employees. The company manufactures and distributes medical and healthcare products.
Winner Medical, Co., Ltd. is a China-based public company founded in 1991. The company manufactures medical devices and healthcare products.
STERIS is an Ireland-based public company founded in 1985. The company provides healthcare and life sciences products and services.
AlphaProTech is a Canada-based public company founded in 1983 with 123 employees. The company manufactures protective apparel and medical products.
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to dental, medical, and veterinary markets.
Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company develops and manufactures medical devices and technologies.
Australia's surgical gowns and drapes market is estimated at USD 30.5 million in 2025.
Australia's surgical gowns and drapes market is projected to reach USD 37.0 million by 2030.
Australia's market is growing at a compound annual growth rate (CAGR) of 3.9% from 2025 to 2030.
Growth in Australia is driven by increasing surgical procedures, hospital modernization, stringent infection control standards, and rising investment in healthcare infrastructure.
Australia's market includes both reusable and single-use surgical gowns and drapes, with selection based on clinical requirements and hospital procurement policies.
The objective of the study is to analyze the key market dynamics of the surgical gowns and drapes sector, including drivers, opportunities, restraints, challenges, and key player strategies. It aims to monitor company developments such as acquisitions, product launches, expansions, agreements, and partnerships among leading players. The competitive landscape is evaluated to assess market players across various parameters within the broad categories of business and product strategy. The market size is estimated using top-down and bottom-up approaches, while market breakdown and data triangulation methods are employed to determine the market size of segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources included industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of the industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
Note 1: Others include sales managers, marketing managers, and product managers. Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
The top-down and bottom-up approaches were used to estimate and validate the total size of surgical gowns and drapes. These methods were also used extensively to estimate the size of various market segments. The research methodology used to estimate the market size includes the following:

After determining the overall market size using the above-mentioned process, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by studying various factors and trends from the demand and supply sides.
A surgical gown is a sterile garment worn by members of the surgical team during a surgical procedure to prevent the transfer of infectious agents. A surgical drape is a sterile material used to cover the patient or equipment during a surgical procedure to prevent the transfer of infectious agents.
Full forecast, segment splits, and company analysis for all Surgical Gowns and Drapes Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report